Skip to main content Scroll Top

Actualités

Posts les plus vus
Clear Filters
EN VUE – REGEnLIFE : Au carrefour de la médecine et de la physique – Magazine Pharmaceutiques n° 335 / Mars 2026
EN VUE – REGEnLIFE : Au carrefour de la médecine et de la physique – Magazine Pharmaceutiques n° 335 / Mars 2026
16 mars 2026
The neuroprotective effect of a new photobiomodulation technique on Aβ25-35 peptide-induced toxicity dramatically impact gut microbiota dysbiosis
6 juin 2018
Does brain-gut photobiomodulation have therapeutic potential in Alzheimer’s Disease? Design of a pivotal sham-controlled, randomized, double-blind, multicentric clinical investigation
Does brain-gut photobiomodulation have therapeutic potential in Alzheimer’s Disease? Design of a pivotal sham-controlled, randomized, double-blind, multicentric clinical investigation
1 décembre 2022
24 octobre 2023

Clinical Trials on Alzheimer’s Disease (CTAD CHINA)

Read the article

Jacques Touchon (MD, PhD), University of Montpellier and Guillaume Blivet (MPH), REGEnLIFE, France.

Partagez cet article